C.P. Schröder
Impact in
-
- HER2/EGFR in Cancer Research
- Cancer Risks and Factors
- Peptidase Inhibition and Analysis
-
- Radiopharmaceutical Chemistry and Applications
- Medical Imaging Techniques and Applications
- Monoclonal and Polyclonal Antibodies Research
Papers in
- Oncology 12
- HER2/EGFR in Cancer Research 5
- Cancer Treatment and Pharmacology 4
- Co-authors
- Elisabeth G.E. de Vries (7 shared papers)Adrienne H. Brouwers (3 shared papers)Bert van der Vegt (3 shared papers)Frederike Bensch (2 shared papers)Stefan Sleijfer (1 shared paper)Johan R. de Jong (1 shared paper)Marjolijn N. Lub–de Hooge (3 shared papers)Steven de Jong (2 shared papers)
- Journals
- Annals of Oncology (4 papers)British Journal of Cancer (1 paper)Journal of Clinical Oncology (1 paper)Breast Cancer Research and Treatment (1 paper)European Journal of Nuclear Medicine and Molecular Imaging (1 paper)
- Partner nations
- NetherlandsGermanyUnited Kingdom
In The Last Decade
C.P. Schröder
16 papers receiving 365 citations
Peers
Comparison fields: 5 of 57
- Oncology 179
- Radiology, Nuclear Medicine and Imaging 138
- Cancer Research 57
- Genetics 25
- Physiology 57
Countries citing papers authored by C.P. Schröder
This map shows the geographic impact of C.P. Schröder's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C.P. Schröder with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C.P. Schröder more than expected).
Fields of papers citing papers by C.P. Schröder
This network shows the impact of papers produced by C.P. Schröder. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C.P. Schröder. The network helps show where C.P. Schröder may publish in the future.
Co-authors
The 25 scholars most cited alongside C.P. Schröder, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 104 | |
| 2 | 2001 | 85 | |
| 3 | 2009 | 74 | |
| 4 | 2017 | 28 | |
| 5 | 2011 | 21 | |
| 6 | 1999 | 20 | |
| 7 | Lapatinib: clinical benefit in patients with HER 2-positive advanced breast cancer. | 2010 | 13 |
| 8 | 2023 | 9 | |
| 9 | 2019 | 8 | |
| 10 | 2020 | 4 | |
| 11 | 2014 | 4 | |
| 12 | 1995 | 2 | |
| 13 | 2012 | 2 | |
| 14 | 2017 | 1 | |
| 15 | 2025 | 1 | |
| 16 | Qualitative and quantitative analyses of F-18-FES and F-18-FDHT uptake in patients with metastatic breast cancer: an interobserver variability study | 2017 | 1 |
| 17 | 2024 | 0 |
About C.P. Schröder
C.P. Schröder is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Radiology, Nuclear Medicine and Imaging, Surgery and Genetics, having authored 17 papers that have together received 377 indexed citations. Recurring topics across this work include HER2/EGFR in Cancer Research (5 papers), Cancer Treatment and Pharmacology (4 papers), Breast Cancer Treatment Studies (3 papers), Medical Imaging Techniques and Applications (3 papers), Radiopharmaceutical Chemistry and Applications (2 papers), Estrogen and related hormone effects (2 papers), Pancreatic function and diabetes (1 paper) and Metabolism, Diabetes, and Cancer (1 paper). The work is most often cited by research in Oncology (179 citations), Radiology, Nuclear Medicine and Imaging (138 citations), Cancer Research (57 citations), Genetics (25 citations) and Physiology (57 citations). C.P. Schröder has collaborated with scholars based in Netherlands, Germany and United Kingdom. Frequent co-authors include Elisabeth G.E. de Vries, Adrienne H. Brouwers, Bert van der Vegt, Frederike Bensch, Stefan Sleijfer, Johan R. de Jong, Marjolijn N. Lub–de Hooge, Steven de Jong, Geke A.P. Hospers and L.F.M.H. de Leij. Their work appears in journals such as Annals of Oncology, British Journal of Cancer, Journal of Clinical Oncology, Breast Cancer Research and Treatment and European Journal of Nuclear Medicine and Molecular Imaging.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.